Skip to main content
OpenTrials
Completed

NCT Number: NCT02343861

The Effectiveness of Tailored Messages on the Usage of Emollient in Patients With Atopic Dermatitis

Atopic dermatitis is the most common chronic inflammatory skin disease in children and severely affects quality of life (QoL) of patients and their parents. The application of topical medications and emollient is the mainstay of the treatment, but complexity of the treatment and lack of self-care knowledge cause poor adherence, leading to therapeutic failure. Adequate education about the chronic disease and its treatment was known to improve the treatment adherence. There are a variety forms like generalized information leaflets and video clips for imparting information to patients and individualized tailoring education was considered more effective way to improve patients' adherence. The aim of this study is to determine the efficacy of tailored education in dermatology area, especially the emollient usage in patients with atopic dermatitis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dermatitis, Atopic Congenital, Hereditary, and Neonatal Diseases and Abnormalities Dermatitis Genetic Diseases, Inborn Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Skin Diseases Skin Diseases, Eczematous Skin Diseases, Genetic Skin and Connective Tissue Diseases

Age range

20 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Dermatology, Seoul National University Boramae Hospital

Seoul, 156-707, South Korea

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • A parent of 0-5 year old children with mild to moderate atopic dermatitis
  • 20 years of age or older
  • Apply emollient for themselves to their children with atopic dermatitis

Exclusion criteria

  • Parents of children with severe atopic dermatitis or showing signs of acute infection (Oozing, vesicles, edema, redness or pain)

Treatment and study plan

Tailored leaflet group

Behavioral

Parents in intervention group will receive an patient education leaflet and watch an educational video about lifestyle recommendations, and the use of emollients. In addition to general information, parents in intervention group will also receive the tailored leaflet including the estimated amount of emollients based on the body surface area.

Other names: Tailored leaflet about the adequate use of emollient

Control Group

Behavioral

Participants (parents of children with atopic dermatitis) in control group will receive an patient education leaflet and watch an educational video about lifestyle recommendations, and the use of emollients.

Primary outcomes

  1. Change of the weekly amount of emollient used

    Time frame: Two weeks

    Parents of patients are asked to bring the emollients to each visit at which time the emollients are weighed.

Secondary outcomes

  1. Average daily number of emollient usage

    Time frame: Two weeks

  2. Average daily number of topical medication (other than emollient) usage

    Time frame: Two weeks

  3. Investigator's Global Assessment (IGA)

    Time frame: Two weeks

    At each visit, disease severity will be assessed using the Investigator's Global Assessment (IGA).

  4. Eczema Area and Severity Index (EASI)

    Time frame: Two weeks

    At each visit, disease severity will be assessed using the Eczema Area and Severity Index (EASI).

Sponsors and collaborators

Lead sponsor

Seoul National University Hospital

Other

Registry information

Official study title

The Effectiveness of Tailored Messages on the Usage of Emollient in Patients With Atopic Dermatitis: A Pilot Study

Important dates

Study start
2015
Primary completion
2015
Study completion
2015
First posted
Jan 22, 2015
Registry last updated
Mar 15, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.